ERISA Ledger · U.S. DOL EBSA Form 5500 (2024)

Inovio Pharmaceuticals, INC.

Official 2024 U.S. DOL Form 5500 summary for Inovio Pharmaceuticals, INC. (Inovio Pharmaceuticals, INC. 401(k) Plan · EIN 33-0969592 · PN 001): $37.55M net assets, 124 active participants, and $21.32 per $10,000 (21.32 bps).

Reported Form 5500 Fee & Service Summary

Plan SponsorInovio Pharmaceuticals, INC.
Filing IdentifierInovio Pharmaceuticals, INC. 401(k) Plan · EIN 33-0969592 · PN 001
Plan Category & State401(k) Defined Contribution (CA)
Asset-Size Peer Cohort$25M-$100M
Plan Net Assets (2024)$37.55M
Active Participants124
Direct Admin Fee Rate$21.32 per $10,000 (21.32 bps)
Cohort Peer Median$19.23 per $10,000 (19.23 bps)
Primary Recordkeeper / ProviderLpl Financial Corporation
Schedule H Line 4a RemittanceTimely Employer Remittance (0 reported on Line 4a)

Browse all 78,373 plans & Schedule C vendors · Methodology · Meru AI